Attributable mortality of nosocomial candidemia, revisited.
暂无分享,去创建一个
Shane Gillespie | M. Pfaller | D. Diekema | L. Herwaldt | S. Messer | Ó. Gudlaugsson | Loreen Herwaldt | S. Gillespie | Kathleen Lee | J. Vande Berg | Jianfang Hu | Michael Pfaller | Olafur Gudlaugsson | Kathleen Lee | Jeff Vande Berg | Jianfang Hu | Shawn Messer | Daniel Diekema
[1] D. McClish,et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] G. Parmigiani,et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] R. Wenzel,et al. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] M. Levenstein,et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. , 1995, The Journal of infectious diseases.
[5] Nnis System,et al. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System. , 1999, American journal of infection control.
[6] Jonathan R. Edwards,et al. and the National Nosocomial Infections Surveillance System Hospitals , 2002 .
[7] R F Woolson,et al. Hospital-acquired candidemia. The attributable mortality and excess length of stay. , 1988, Archives of internal medicine.
[8] B. Plikaytis,et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] ohn,et al. COMPARISON OF CASPOFUNGIN AND AMPHOTERICIN B FOR INVASIVE CANDIDIASIS , 2002 .
[10] R. Gaynes,et al. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] D. Snydman,et al. Attributable mortality of Stenotrophomonas maltophilia bacteremia. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] Nnis System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.
[13] Jeanne E. Zack,et al. Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit , 2002, Critical care medicine.
[14] J. Myers,et al. Nosocomial fungemia in a large community teaching hospital. , 1987, Archives of internal medicine.
[15] J. Sobel,et al. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. , 1989, Reviews of infectious diseases.
[17] J. Sobel,et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] J. Enders,et al. Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.
[19] M. Pfaller,et al. Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal Susceptibility , 2002, Journal of Clinical Microbiology.
[20] A. Macías. Impact of Nosocomial Infections on Outcome Myths and Evidence , 2000, Infection Control & Hospital Epidemiology.
[21] A. Callow,et al. Candida Infections in Surgical Patients , 1983, Annals of surgery.
[22] D. Snydman,et al. Attributable mortality of bacteremia associated with the Bacteroides fragilis group. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] J. Sobel,et al. Invasive candidiasis: turning risk into a practical prevention policy? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] R. Wenzel,et al. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay , 1990 .
[25] D. Pittet,et al. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.
[26] M. Levenstein,et al. A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia , 1994 .
[27] B. Wong,et al. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. , 1985, Reviews of infectious diseases.
[28] W. Kreisel,et al. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] C. Watanakunakorn,et al. Hospital-acquired fungemia. Its natural course and clinical significance. , 1979, The American journal of medicine.
[30] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[31] D. Pittet,et al. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] J. Sobel,et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] V. Fraser,et al. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.